CAMPTOSAR INJECTION 100mg (5ml vial) contains Irinotecan, a chemotherapeutic agent used primarily in the treatment of colorectal cancer. It works by inhibiting DNA replication in cancer cells, thereby preventing their growth and division.
The dosage of CAMPTOSAR is typically determined by the healthcare provider based on individual patient factors, including body weight and overall health. It is usually administered as an intravenous infusion. Follow the prescribed dosage regimen provided by your healthcare professional.
Common side effects of CAMPTOSAR may include:
If you experience severe side effects or signs of an allergic reaction, seek medical attention immediately.
Inform your doctor about any allergies, medical conditions, or medications you are currently taking to avoid potential interactions.
CAMPTOSAR is not recommended during pregnancy. Discuss with your healthcare provider if you are pregnant or planning to become pregnant.
CAMPTOSAR is administered through an intravenous infusion, typically in a clinical setting under the supervision of a healthcare professional.